168 related articles for article (PubMed ID: 21753776)
1. Lactotripeptides effect on office and 24-h ambulatory blood pressure, blood pressure stress response, pulse wave velocity and cardiac output in patients with high-normal blood pressure or first-degree hypertension: a randomized double-blind clinical trial.
Cicero AF; Rosticci M; Gerocarni B; Bacchelli S; Veronesi M; Strocchi E; Borghi C
Hypertens Res; 2011 Sep; 34(9):1035-40. PubMed ID: 21753776
[TBL] [Abstract][Full Text] [Related]
2. Predictors of the short-term effect of isoleucine-proline-proline/valine-proline-proline lactotripeptides from casein on office and ambulatory blood pressure in subjects with pharmacologically untreated high-normal blood pressure or first-degree hypertension.
Cicero AF; Rosticci M; Ferroni A; Bacchelli S; Veronesi M; Strocchi E; Borghi C
Clin Exp Hypertens; 2012; 34(8):601-5. PubMed ID: 22574612
[TBL] [Abstract][Full Text] [Related]
3. Effect of Lactotripeptides (Isoleucine-Proline-Proline/Valine-Proline-Proline) on Blood Pressure and Arterial Stiffness Changes in Subjects with Suboptimal Blood Pressure Control and Metabolic Syndrome: A Double-Blind, Randomized, Crossover Clinical Trial.
Cicero AF; Colletti A; Rosticci M; Cagnati M; Urso R; Giovannini M; Borghi C; D'Addato S
Metab Syndr Relat Disord; 2016 Apr; 14(3):161-6. PubMed ID: 26683986
[TBL] [Abstract][Full Text] [Related]
4. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic effects of lactotripeptides from casein hydrolysate in Mediterranean normotensive subjects and patients with high-normal blood pressure: a randomized, double-blind, crossover clinical trial.
Cicero AF; Rosticci M; Veronesi M; Bacchelli S; Strocchi E; Melegari C; Grandi E; Borghi C
J Med Food; 2010 Dec; 13(6):1363-8. PubMed ID: 21091250
[TBL] [Abstract][Full Text] [Related]
6. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
7. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of low felodipine dose monotherapy in mild-to-moderate hypertension: a comparison between office and ambulatory blood pressure monitoring.
Podjarny E; Korzets Z; Bernheim J
J Hum Hypertens; 1996 Sep; 10 Suppl 3():S153-6. PubMed ID: 8872849
[TBL] [Abstract][Full Text] [Related]
9. Ile-Pro-Pro and Val-Pro-Pro tripeptide-containing milk product has acute blood pressure lowering effects in mildly hypertensive subjects.
Turpeinen AM; Ehlers PI; Kivimäki AS; Järvenpää S; Filler I; Wiegert E; Jähnchen E; Vapaatalo H; Korpela R; Wagner F
Clin Exp Hypertens; 2011; 33(6):388-96. PubMed ID: 21649532
[TBL] [Abstract][Full Text] [Related]
10. The blood pressure lowering effect of lactotripeptides and salt intake in 24-h ambulatory blood pressure measurements.
Yamasue K; Morikawa N; Mizushima S; Tochikubo O
Clin Exp Hypertens; 2010 Jul; 32(4):214-20. PubMed ID: 20608891
[TBL] [Abstract][Full Text] [Related]
11. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
12. Association of masked hypertension and left ventricular remodeling with the hypertensive response to exercise.
Sharman JE; Hare JL; Thomas S; Davies JE; Leano R; Jenkins C; Marwick TH
Am J Hypertens; 2011 Aug; 24(8):898-903. PubMed ID: 21525966
[TBL] [Abstract][Full Text] [Related]
13. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F;
Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term intake of lactotripeptides on cardiovascular risk factors in hypertensive subjects.
Jauhiainen T; Niittynen L; Orešič M; Järvenpää S; Hiltunen TP; Rönnback M; Vapaatalo H; Korpela R
Eur J Clin Nutr; 2012 Jul; 66(7):843-9. PubMed ID: 22617279
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
[TBL] [Abstract][Full Text] [Related]
16. Uncontrolled isolated office hypertension is associated with subclinical markers of cardiovascular disease in hypertensive type 2 diabetic patients.
Salles GF; Teixeira GB; Leite NC; Muxfeldt ES; Cardoso CR
Hypertens Res; 2010 Aug; 33(8):819-24. PubMed ID: 20535116
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
Ibrahim MM; el-Boghdadly B; Zaghloul SS
J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
[TBL] [Abstract][Full Text] [Related]
18. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.
Dhakam Z; McEniery CM; Yasmin ; Cockcroft JR; Brown MJ; Wilkinson IB
Am J Hypertens; 2006 Feb; 19(2):214-9. PubMed ID: 16448896
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
[TBL] [Abstract][Full Text] [Related]
20. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
